[治疗儿童和青少年中药休息的影响 治疗儿童和青少年中药休息的影响 治疗儿童和青少年中药休息的影响 治疗儿童和青少年中药休息的影响 治疗儿童和青少年中药休息的影响 治疗儿童和青少年中药休息的影响 治疗儿童和青少年中药休息的影响
Ida Tagesen1, Niels Bilenberg1
1Børne- og ungdomspsykiatrisk afdeling, Psykiatrien i Region Syddanmark.
Ugeskrift for laeger
|February 25, 2026
概括
药物假期可以使患有减肥,失眠或耐受症的患者受益. 制定明确的指导方针对于青少年和成人护理的有效实施至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 患者护理 患者护理
背景情况:
- 药物假期是一种治疗策略,涉及暂时停止服用药物.
- 它们的应用在治疗慢性疾病和治疗坚持方面尤其重要.
- 现有文献表明,各种患者群体可能从这种方法中受益.
研究的目的:
- 审查有关毒品节的相关性和应用的文献.
- 为了确定患者群体和条件,药物假期是指定的.
- 突出进一步研究和具体指导方针的需要.
主要方法:
- 进行了全面的文献审查.
- 分析了对不同患者人口统计和病情的药物假期的研究.
- 该审查综合了关于疗效,适应症和挑战的研究结果.
主要成果:
- 药物假期对体重减轻和BMI下降的患者是有益的.
- 青少年可能利用毒品假期来评估治疗需求和责任.
- 失眠和获得的耐受性也被确定为药物假期的相关指示.
结论:
- 药物假期是针对特定患者群体的相关干预措施,包括那些体重减轻,青少年,失眠或耐受症患者.
- 进一步的研究是必要的,以充分了解毒品假期的范围和影响.
- 为医疗保健专业人员,家长和患者制定明确的指南对于最佳应用至关重要.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.5K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
11.0K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
1.1K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.0K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion
332
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332
Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
Adrenergic Agonists: Mixed-Action Agents
1.6K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.6K
